Study on the clinical therapeutic effect of emergency severe pneumonia complicated with septic shock
急诊重症肺炎合并感染性休克临床治疗效果研究

摘要

目的 研究急诊重症肺炎合并感染性休克患者的临床治疗方案及效果。方法 随机选取我院急诊接收的重症肺炎患者68例，以随机数字表法将入选的病例分成观察组34例和对照组34例，对照组给予头孢哌酮钠舒巴坦钠治疗，观察组在对照组用药基础上添加美罗培南治疗，分析对比两组治疗效果。结果 观察组患者的症状改善、机械通气和住院所用时间短于对照组，患者体内炎性因子水平与对照组相比显著降低，最终获得的治疗总有效率高于对照组，并发症发生率低于对照组，（P＜0.05）。结论 对急诊重症肺炎合并感染性休克患者采取头孢哌酮钠舒巴坦钠联合美罗培南方案治疗，可获得更加理想的治疗效果，尽早改善患者临床症状，降低体内炎性因子水平,减少并发症发生。

Abstract

Objective To study the clinical treatment plan and effect of emergency patients with severe pneumonia complicated with septic shock.
Methods A total of 68 patients with severe pneumonia admitted to the emergency department of our hospital were randomly selected. The selected cases were divided into an observation group of 34 cases and a control group of 34 cases by the random number table method. The control group was treated with cefoperazone sodium and sulbactam sodium, and the observation group was treated with meropenem in addition to the medication of the control group. The therapeutic effects of the two groups were analyzed and compared.
Results The symptom improvement, mechanical ventilation and hospitalization time of patients in the observation group were shorter than those in the control group. The levels of inflammatory factors in the patients' bodies were significantly lower than those in the control group. The total effective rate of treatment finally obtained was higher than that in the control group, and the incidence of complications was lower than that in the control group (P < 0.05).
Conclusion   For emergency patients with severe pneumonia complicated with septic shock, the treatment regimen of cefoperazone sodium sulbactam sodium combined with meropenem can achieve more ideal therapeutic effects, improve the clinical symptoms of patients as soon as possible, reduce the levels of inflammatory factors in the body, and reduce the occurrence of complications.